AKI timing separated a high-risk hepatitis cohort into sharply different prognostic groups
In alcohol-associated hepatitis, kidney injury is not a background complication. It is part of the mortality story, and this multinational cohort shows that the timing of acute kidney injury changes how that story unfolds.
Across 581 patients enrolled in the Global AlcHep Prospective Database, investigators divided renal dysfunction into three clinically familiar states: no AKI, prevalent AKI present at admission, and incident AKI that developed during hospitalization. The 90-day mortality rate was 18.2%, with 11 liver transplantations accounting for 1.9% of the cohort. Even before any trajectory analysis, the renal signal was hard to miss: both prevalent and incident AKI independently carried excess mortality risk.
Incident AKI carried the same danger as kidney injury already present on admission
The most clinically important finding is also the least intuitive. Patients who developed incident AKI during the admission faced a mortality hazard similar in magnitude to those who arrived with prevalent AKI, despite entering the hospital with lower measured liver disease severity.
Baseline severity favored the incident-AKI group. Median mDF was 59.8 compared with 69.3 in those with prevalent AKI, and ACLF grade 3 occurred less often, 23.4% versus 45.3%. Even so, incident AKI conferred a subdistribution hazard ratio for 90-day mortality of 2.18, with a 95% confidence interval of 1.19 to 3.99. Prevalent AKI also remained harmful, with an sHR of 1.80 and a 95% confidence interval of 1.02 to 3.16.
In practical terms, renal injury that emerges after admission should not be treated as a late or secondary event. The data suggest it signals a sharp physiologic turning point, one in which renal reserve is failing amid severe systemic inflammation, circulatory dysfunction, and hepatic decompensation.
Functional injury dominated admission AKI, while hospital-acquired AKI looked more structural
Etiology added another layer of meaning. Among patients with prevalent AKI, 84% had functional renal injury. Incident AKI looked different: 44% showed structural injury.
That split matters biologically. Functional AKI in alcohol-associated hepatitis often reflects hemodynamic collapse, renal vasoconstriction, and reduced effective arterial blood volume rather than immediate tubular damage. Structural injury implies a deeper renal insult, one more likely to reflect sustained hypoperfusion, inflammatory injury, or direct nephrotoxic stress during hospitalization. The higher structural burden in incident AKI helps explain why later-onset kidney injury was not benign even though those patients entered with less severe liver scores.
A single creatinine rise during the hospital course can therefore represent more than a laboratory fluctuation. In this setting, it may mark the transition from potentially reversible hemodynamic compromise to intrinsic kidney damage with a much narrower path back to recovery.
Seven-day trajectory separated reversible AKI from the group heading toward death
The study becomes even more clinically useful when it moves from admission status to early renal trajectory. Among 457 patients who survived the first 7 days, prevalent AKI split into two clearly different prognostic paths. Those without progression had mortality similar to patients without AKI, with an sHR of 1.27 and a p value of 0.52. By contrast, prevalent AKI with progression had the worst outcome in the analysis, with an sHR of 3.34 and a 95% confidence interval of 1.44 to 7.77.
The bedside implication is straightforward. A patient with AKI on day 1 is not automatically in the same risk category as a patient whose renal function continues to worsen through the first week. Early stabilization appears to identify a subgroup whose kidney injury may be reversible or at least not relentlessly progressive. Worsening creatinine, by contrast, identifies a much more dangerous phenotype, likely reflecting ongoing circulatory failure, persistent inflammatory injury, or both.
Mortality risk rose beyond baseline liver scores alone
Alcohol-associated hepatitis remains one of the most difficult syndromes in hepatology because liver severity scores do not fully capture extrahepatic collapse. This cohort reinforces that limitation without overstating it. The presence of AKI, and especially the direction of renal change over time, added prognostic information beyond baseline disease severity.
That point has direct implications for inpatient management. If the kidney worsens after admission, the clinical team should interpret the trajectory as a marker of systemic instability rather than a simple laboratory complication. The highest-risk patients may be those moving from compensated renal stress into persistent or structural injury, a transition that should prompt aggressive reassessment of volume status, infection, hemodynamics, and transplant candidacy when appropriate.
Why the timing of kidney injury changes the meaning of the diagnosis
The findings align with known pathophysiology in alcohol-associated hepatitis. Severe hepatic inflammation can drive profound circulatory dysregulation, renal vasoconstriction, and susceptibility to AKI. When kidney injury is already present on admission, clinicians are seeing the consequence of disease that has likely been unfolding before hospitalization. When AKI develops later, the kidney is failing in the face of ongoing in-hospital stressors, and the structural injury burden may already be higher.
That difference helps explain why incident AKI, even in a cohort with lower liver severity scores, carried mortality risk comparable to prevalent AKI. It also explains why early trajectory is so informative: a kidney that stops deteriorating may be signaling that the systemic injury has stabilized, while a kidney that continues to worsen is often tracking with multi-organ decline.
What this multicenter cohort changes at the bedside
This study does not treat AKI as a binary checkbox in alcohol-associated hepatitis. It shows that the timing of kidney injury, its apparent functional or structural character, and its first-week course each carry prognostic weight.
For hospital teams, the message is specific. Admission AKI and in-hospital AKI both require immediate attention. Early stabilization is reassuring only in a relative sense, because progression over the first 7 days identifies the subgroup with the greatest mortality risk. A patient whose creatinine continues to rise after admission is not simply “another AKI case”; that patient sits in a distinctly higher-risk category that may warrant closer monitoring, earlier escalation, and rapid hepatology-nephrology coordination.
The study was limited to 90-day outcomes and did not report whether specific kidney-directed interventions altered the renal trajectory groups. The next question is whether early treatment strategies can prevent progression from functional injury to structural injury, and whether that shift can change survival in alcohol-associated hepatitis.